Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioGenerics Logo
BioGenerics Growth Score
4
CB Rank
638988
Heat Score
28
BioGenerics focuses on the distribution of pharmaceutical and natural raw materials, the production and marketing of generic medicines.
Founded
obfuscation
PrivateDebt Financing Hamburg, Hamburg, Germany1-10 www.biogenerics.net
Biotechnology
Medical
Pharmaceutical
Overview

BioGenerics
Total Funding
obfuscation
Growth Score
4
Heat Score
28

Total Funding
obfuscation
obfuscation
Debt Financing raised
obfuscation
Growth Score4
-5 pts
in past quarter
Heat Score 28
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BioGenerics

CB Rank
638988
BioGenerics focuses on the distribution of pharmaceutical and natural raw materials, the production and marketing of generic medicines.
Founded
obfuscation
PrivateDebt Financing Hamburg, Hamburg, Germany1-10 www.biogenerics.net
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Debt Financing
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Biogenerics Pharma GmbH
Operating Status Active
Company Type For Profit
Founders  Wolfgang Roehr
Phone Number +49 (0) 40 41 35 74 11
Contact Email roehr@biogenerics.net
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

BioG MicroTabs Ingredient System
A pharmaceutical ingredient delivery system designed for precise dosing and administration of active compounds.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing
obfuscation
Debt Financing - BioGenerics Logo
Debt Financing - BioGenerics
—
obfuscation
— Debt Financing

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$274.6KThis year, BioGenerics is projected to spend $274.6K on IT, according to Aberdeen.

Actively Used Products

2BioGenerics uses 2 technology products and services including Apache Server, F5 NGINX, and  GoDaddy Premium DNS, according to G2 Stack.

Active Website Tech Count

11BioGenerics is actively using 11 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

2The intellectual property of BioGenerics includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BioGenerics's headquarters? BioGenerics is located in Hamburg, Hamburg, Germany.When was the last funding round for BioGenerics? BioGenerics closed its last funding round on
obfuscation
from a Debt Financing round.Who are BioGenerics's competitors? Alternatives and possible competitors to BioGenerics may include Teva Pharmaceuticals, Sandoz International, and  Aurobindo Pharma.How much funding has BioGenerics raised to date? BioGenerics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|